
    
      The objectives of this study are to evaluate the therapeutic equivalence and safety of
      Clindamycin and Benzoyl Peroxide Gel 1%/5% (Taro Pharmaceuticals Inc.) and BenzaClinÂ®
      (clindamycin 1%/benzoyl peroxide 5%) Topical Gel (Sanofi Aventis, US) in the treatment of
      acne vulgaris and to demonstrate the superiority of the efficacy of the test and reference
      products over the placebo control
    
  